Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Explore the critical factors to consider when choosing no fee travel cards. Ensure your card fits your travel needs.
24,592 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A targeted international dividend fund surged 26% over the past year and yields around 3.1%, while broad overseas exp...
Meta Platforms is dialing up AI infrastructure spending, guiding 2026 capex to $125-145 billion after a strong Q1. Th...
Texas Instruments preps for July earnings with a guidance-led breakout in industrial and data-center demand, plus a f...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
Jim Cramer signals resilience in the AI-security wave, underscoring a ongoing hunt for the next DeepSeek. Here are fi...
The Roundhill Magnificent Seven ETF has delivered strong gains since its April 2023 start, but a growing concentratio...
Bitcoin has shed about half its value from October peaks, testing investor nerves. Retail buyers on Coinbase persist,...
Comfort Systems USA is set to report Q4 FY2025 after the bell, with shares up about 65% over the past year. Analysts ...
Microsoft trades at a decade-low multiple as AI tools expand and Copilot adoption lags. Investors weigh the AI upside...
Tariff policy volatility follows a high court ruling, and a new AI platform aims to help firms weather the disruption...
Illinois and Hawaii join Wisconsin and Washington in tightening real estate listing rules, signaling a broader state-...